Race Identified as Prognostic Indicator in Black Patients With AML

A 30-year retrospective analysis of clinical trials involving patients with acute myeloid leukemia (AML) receiving intensive chemotherapy demonstrated that Black race is an independent prognostic factor for lower survival outcomes in patients,…